SCHEMBL7545686

SCHEMBL7545686

Cc1cc(C)n2ncc(Br)c2n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.57
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
ALDH1A1 P00352 7/20 0.48
PKM P14618 1/20 0.48
HTR6 P50406 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
GSK3B P49841 1/20 0.47
MAPT P10636 3/20 0.47
POLB P06746 2/20 0.43
HPGD P15428 3/20 0.42
PIK3CG P48736 1/20 0.42
GAA P10253 1/20 0.41
HSD17B10 Q99714 2/20 0.41
TSHR P16473 1/20 0.41
GBA1 P04062 2/20 0.41
CHEK1 O14757 1/20 0.41
CCNA2 P20248 1/20 0.41
CDK2 P24941 1/20 0.41
CCNA1 P78396 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12953199 0.81 MAPT (0.56) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL14050842 0.81 GSK3B (0.42) KDM4EMEN1KMT2AALDH1A1PKM
SCHEMBL8288618 0.80 KDM4E (0.61) KDM4EMEN1KMT2AALDH1A1PKM
SCHEMBL14043374 0.79 GSK3B (0.50) KDM4EMEN1KMT2AALDH1A1PKM
SCHEMBL11609944 0.79 GSK3B (0.46) KDM4EMEN1KMT2AALDH1A1SMN1; SMN2
SCHEMBL14043299 0.78 CDK2 (0.40) KDM4EMEN1KMT2AALDH1A1PKM
SCHEMBL11605087 0.77 KDM4E (0.57) KDM4EMEN1KMT2AALDH1A1PKM
SCHEMBL7460087 0.77 KDM4E (0.57) KDM4EMEN1KMT2AALDH1A1PKM
SCHEMBL11605145 0.77 KDM4E (0.57) KDM4EMEN1KMT2AALDH1A1PKM
SCHEMBL11606275 0.77 KDM4E (0.57) KDM4EMEN1KMT2AALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4093617-A ENZYME INHIBITORS ICN PHARMACEUTICALS, INC. (US) 1978-06-06 US claimed
WO-2008130570-A1 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2008-10-30 WO disclosed
WO-2008130569-A1 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2008-10-30 WO disclosed
EP-1171122-A4 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO INC (US) 2002-05-29 EP disclosed
EP-1171122-A1 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY Merck & Co., Inc. (US) 2002-01-16 EP disclosed
US-6248755-B1 ANTIINFLAMMATORY AGENTS; ANTIALLERGENS; AUTOIMMUNE DISEASES MERCK & CO., INC. 2001-06-19 US disclosed
WO-2000059502-A1 PYRROLIDINE MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY MERCK & CO., INC. (US) 2000-10-12 WO disclosed
US-4093617-A ENZYME INHIBITORS ICN PHARMACEUTICALS, INC. (US) 1978-06-06 US disclosed
US-4036840-A ENZYME INHIBITORS ICN PHARMACEUTICALS (US) 1977-07-19 US disclosed